Now showing items 1-4 of 4

    • Cancer incidence in heart transplant recipients with previous neoplasia history 

      Delgado Jiménez, Juan Francisco; Alonso-Pulpón, Luis; Mirabet, Sonia; Almenar-Bonet, Luis; Villa, F.P.; González-Vílchez, Francisco; Palomo, Jesús; Blasco-Peiró, Teresa; García-Cosío, M. Dolores; González-Costello, José; De la Fuente-Galán, Luis; Rábago, Gregorio; Lage-Gallé, Ernesto; Pascual Figal, Domingo A.; Molina, B.D.; Arizón-del-Prado, José M.; Muñiz, Javier; Crespo-Leiro, María Generosa (Wiley, 2016-02-03)
      [Abstract] Neoplasm history increases morbidity and mortality after solid organ transplantation and has disqualified patients from transplantation. Studies are needed to identify factors to be considered when deciding on ...
    • Chronic renal dysfunction in maintenance heart transplant patients: the ICEBERG study 

      González-Vílchez, Francisco; Arizón-del-Prado, José M.; Segovia-Cubero, Javier; Almenar-Bonet, Luis; Crespo-Leiro, María Generosa; Palomo, Jesús; Delgado Jiménez, Juan Francisco; Mirabet, Sonia; Rábago, Gregorio; Pérez-Villa, Félix; Díaz, Beatriz; Sanz, M.L.; Pascual, Domingo; Fuente, Luis de la; Guinea, G. (Elsevier, 2014-02-05)
      [Abstract] Chronic renal dysfunction (CRD) is a major complication after heart transplantation. We sought to describe the renal function over time, to assess the risk factors associated with CRD development, and to evaluate ...
    • Conversion from immediate-release tacrolimus to prolonged-release tacrolimus in stable heart transplant patients: a retrospective study 

      González-Vílchez, Francisco; Delgado Jiménez, Juan Francisco; Palomo, Jesús; Mirabet, Sonia; Díaz Molina, Beatriz; Almenar-Bonet, Luis; Arizón-del-Prado, José M.; Rangel-Sousa, Diego; Pérez-Villa, Félix; Garrido, Iris P.; Fuente, Luis de la; Gómez-Bueno, Manuel; Sanz-Julve, Marisa; Crespo-Leiro, María Generosa (Elsevier, 2019-07-01)
      [Abstract] Background Lifelong adherence with post-transplant immunosuppression is challenging, with nonadherence associated with greater acute rejection (AR) risk. Methods This retrospective study evaluated conversion ...
    • Influence of induction therapy, immunosuppressive regimen and anti-viral prophylaxis on development of lymphomas after heart transplantation: data from the spanish post–heart transplant tumour registry 

      Crespo-Leiro, María Generosa; Alonso-Pulpón, Luis; Arizón-del-Prado, José M.; Almenar, Luis; Delgado-Jiménez, Juan F.; Palomo, Jesús; Manito, Nicolás; Rábago, Gregorio; Lage, Ernesto; Díaz, Beatriz; Roig, Eulàlia; Pascual, Domingo; Blasco, Teresa; Fuente, Luis de la; Campreciós, Marta; Vázquez de Prada, José A.; Muñiz, Javier (Elsevier, 2007-11-20)
      [Abstract] Background. Lymphoma after heart transplantation (HT) has been associated with induction therapy and herpesvirus infection. It is not known whether anti-viral agents administered immediately after HT can reduce ...